We look forward to an in-person meeting, offering the opportunity for colleagues and Breast Cancer Trials members to connect at the Sofitel Brisbane, for #BCT2026. The registration desk will be open from 8:00 AM Wednesday, Thursday, Friday and Saturday.
Attending the ASM has never been cheaper and easier. We are thrilled to announce that BCT has partnered with Qantas to support our delegates for the upcoming 2026 ASM. As part of this collaboration, Qantas is offering discounts on selected flights for all registered delegates who are travelling to the event from within Australia and internationally.
Qantas is Australia’s most trusted airline, with a reputation for delivering excellent service, safety, and reliability. We are proud to have them on board as our official airline partner for the 2026 ASM, ensuring delegates can travel in comfort and style to our event. To find out more about the select discounted flights, delegates can simply book via the dedicated link below using the access code provided during registration. If you have not received your code, please email the ASM secretariat.
Please note, the discount is only available from 29 January.
Breast Cancer Trials (BCT) is a world-leading clinical trials research organisation, dedicated to finding new and better treatments and prevention strategies for people affected by this disease. Our research program involves multicentre national and international clinical trials and brings together more than 1,000 researchers across 118 institutions throughout Australia and New Zealand.
This is the official website for our 2026 Annual Scientific Meeting (ASM), and this year is the 47th year of the conference, which will be held in Brisbane, QLD, Australia. Our ASM hosts a number of internationally renowned guest speakers including key BCT researchers. Delegates include leading Australian and New Zealand medical practitioners, clinicians, and clinical trials management personnel.
The full and extensive program will include three days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research, and other research developments. The program will also include abstracts, and debates, and is followed by a Trainee and Early Career day on Saturday.
Thank you to Daiichi-Sankyo | AstraZeneca for being our Platinum Sponsor at #BCT2026. Find out more about sponsorship opportunities at our upcoming conference.
The BCT ASM is not open to the general public to attend.
The 47th Annual Scientific Meeting will be held in Brisbane, Queensland.
The conference website undergoes regular updates to provide attendees with the latest information regarding the program, esteemed guest speakers, grant and awards opportunities, as well as registration updates. We encourage you to revisit the site at a later date for the most up-to-date information. Please note this is a preliminary program and is subject to change.
This is a closed meeting for CAP members only.
The Q&A event, moderated by Author and Journalist Annabel Crabb, will be held at the State Library of Queensland. Further information about this session will be provided over the upcoming months.
Our annual Trials Coordination Forum is a fantastic opportunity for BCT staff and their colleagues from member sites to meet in a relaxed, educational, and informative environment.
A Concept Development Workshop will be held by Breast Cancer Trials at the 47th Annual Scientific Meeting, to provide an opportunity for members and non-members to present new research ideas.
More information about the Roche Lunch Symposium will be made available in the upcoming months.
A Concept Development Workshop will be held by Breast Cancer Trials at the 47th Annual Scientific Meeting, to provide an opportunity for members and non-members to present new research ideas.
New to the ASM program for 2026, the Scientific Welcome Session sets the tone for the meeting with an inspiring keynote from an international speaker, offering a global perspective and insight into the evolving breast cancer clinical trials landscape. This session provides a strong scientific opening to the ASM, bringing delegates together to reflect on current challenges, emerging ideas, and opportunities for collaboration.
More information about the Novartis Dinner Symposium will be made available in the upcoming months.
The Faculty Dinner is for invitees only, additional guests are welcome. If you would like to bring an additional guest, please email the ASM Secretariat at asm@bctrials.org.au. Please note, the dress code for the Faculty Dinner is smart casual.
More information about the Lilly Breakfast Symposium will be made available in the upcoming months.
The Changing Paradigm for Treating HER2+ eBC
More information about the AstraZeneca | Daiichi-Sankyo Lunch Symposium will be made available in the upcoming months.
This meeting is open to Breast Cancer Trials members only.
Please note, the Conference Dinner has a maximum capacity. Once exceeded, delegates will be added to a cancellation list. More information about this can be found on our registration page.
The dress code for the Conference Dinner is cocktail.
The Role of ADCs in Metastatic TNBC
More information about the Gilead Breakfast Symposium will be made available in the upcoming months.
More information about the Pfizer Lunch Symposium will be made available in the upcoming months.
Please note, the Trainee and Early Career dinner has a maximum capacity. Once exceeded, attendees will be added to a cancellation list. If you have any questions or concerns about this please contact the ASM Secretariat at asm@bctrials.org.au.
The Breast Cancer Trials (BCT) Board of Directors are pleased to offer the following Travel Grants and Awards to recognise the valuable contributions of BCT members, to the Group’s clinical trials research program. All awards are at the discretion of the Board of Directors.
There are many benefits to becoming a member of BCT, including reduced registration at the ASM each year. All membership applications need to be received and supported by two proposers by Monday 1 June 2026 to be eligible to receive discounted registration for the 2026 ASM. The outcome of applications will be provided on Friday 12 June 2026. Any memberships received before the 1 June 2026 deadline will be eligible for the discounted rate.
You will be able to access the member registration rate after Board approval is confirmed. Please note that current involvement in a BCT clinical trial does not automatically confirm BCT membership. Please contact membership@bctrials.org.au if you have any questions regarding BCT membership.
There are two BCT membership categories: Full Member and Affiliate Member. If you would like more information or to apply for a membership, visit the link below.
Dr Gabi Metz Radiation Oncologist and 2025 Clinical Fellow.
BCT is working to ensure that our annual conference is following environmentally sustainable practices through carbon offsetting our flights, re-using lanyards, and reducing paper waste through our conference website and app, which are used by our delegates and sponsors.
BCT is proud to be working with companies who share the same values when it comes to sustainability. Visit the links below to find out more about the sustainability practices of the Sofitel Brisbane Central, and find out more about the sustainability practices we are implementing at Breast Cancer Trials.
For more information about Brisbane, or for tips when it comes to planning your trip, click the button below.